Oculis Holding AG OCS
NASDAQ OCS
$7.81 -0.06 (-0.74%)
As of: Oct 22, 2026 · 10:36 AM EDT

Oculis Holding AG (OCS) Long-Term Debt Issuances (2023 - 2025)

Updated

Analysis

Oculis Holding AG (OCS) Long-Term Debt Issuances (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,163.39 Bn 1,131.97 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 634.39 Bn 552.91 Bn 17.26 Bn -
3 AbbVie 502.68 Bn 475.79 Bn 12.70 Bn -
4 Merck 377.37 Bn 331.74 Bn 12.21 Bn -
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 266.55 Bn 240.24 Bn 12.86 Bn -
7 Amgen 240.56 Bn 195.96 Bn 7.24 Bn -
8 Gilead Sciences 193.19 Bn 167.38 Bn 6.22 Bn -
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Oculis Holding AG 410.89 Mn -600.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -21,008.39
Dec 31, 2024 -24,007.35
Dec 31, 2023 -6,735.94
API Access

Oculis Holding AG Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=OCS&period=max&api_key=YOUR_API_KEY